BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9242218)

  • 1. Allelic imbalance at chromosome 1q21 in Wilms tumor.
    Law MH; Algar E; Little M
    Cancer Genet Cytogenet; 1997 Aug; 97(1):54-9. PubMed ID: 9242218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline and somatic abnormalities of chromosome 7 in Wilms' tumor.
    Wilmore HP; White GF; Howell RT; Brown KW
    Cancer Genet Cytogenet; 1994 Oct; 77(2):93-8. PubMed ID: 7954327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. +P5 (D1S3309E), a novel target binding site for the Wilms' tumour suppressor 1 (WT1) gene, maps to human chromosome 1q21-->22.
    Negus K; Holmes GH; Wicking C; Wainwright BJ; Little MH
    Cytogenet Cell Genet; 1996; 72(4):306-9. PubMed ID: 8641136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further chromosome studies on Wilms' tumor cells of patients without aniridia.
    Kaneko Y; Kondo K; Rowley JD; Moohr JW; Maurer HS
    Cancer Genet Cytogenet; 1983 Oct; 10(2):191-7. PubMed ID: 6311403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytogenetic findings in Wilms' tumor].
    Hohenfellner K; Holl M; Gutjahr P; Zabel B
    Klin Padiatr; 1989; 201(4):293-8. PubMed ID: 2550699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
    Kaneko Y; Takeda O; Homma C; Maseki N; Miyoshi H; Tsunematsu Y; Williams BG; Saunders GF; Sakurai M
    Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
    Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
    Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11.
    Radice P; Perotti D; De Benedetti V; Mondini P; Radice MT; Pilotti S; Luksch R; Fossati Bellani F; Pierotti MA
    Genomics; 1995 Jun; 27(3):497-501. PubMed ID: 7558032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic changes in Wilms' tumors.
    Solis V; Pritchard J; Cowell JK
    Cancer Genet Cytogenet; 1988 Sep; 34(2):223-34. PubMed ID: 2842036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A third Wilms' tumor locus on chromosome 16q.
    Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
    Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of chromosome 11p imbalances in aniridia and Wilms tumor patients.
    Busch M; Leube B; Thiel A; Schanze I; Beier M; Royer-Pokora B
    Am J Med Genet A; 2013 May; 161A(5):958-64. PubMed ID: 23494989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trisomy 1q generating translocations in Wilms tumor.
    Betts DR; Ilg EC; Oezahin H; von der Weid N; Niggli FK
    Cancer Genet Cytogenet; 1999 Jul; 112(2):138-43. PubMed ID: 10686941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome abnormalities in tumor cells from patients with sporadic Wilms' tumor.
    Kondo K; Chilcote RR; Maurer HS; Rowley JD
    Cancer Res; 1984 Nov; 44(11):5376-81. PubMed ID: 6091875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P; Telzerow P; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers.
    Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27301. PubMed ID: 29968962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S; Tomlinson G; Nisen P; Haber DA
    Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
    Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
    Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
    Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
    Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cytogenetic study of Wilms' tumor.
    Slater RM; de Kraker J; Voûte PA; Delemarre JF
    Cancer Genet Cytogenet; 1985 Jan; 14(1-2):95-109. PubMed ID: 2981155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.